{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:42Z","timestamp":1792686282440,"version":"4.5.0"},"reference-count":115,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010949","name":"Copenhagen Trial Unit","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010949","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193924","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T18:34:34Z","timestamp":1520534074000},"page":"e0193924","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8025-1939","authenticated-orcid":true,"given":"Naqash J.","family":"Sethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus C.","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccl.2015.12.002","article-title":"The epidemiology of atrial fibrillation and stroke","volume":"34","author":"F Pistoia","year":"2016","journal-title":"Cardiology Clinics"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation","volume":"14","author":"AJ Camm","year":"2012","journal-title":"Europace"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"S Stewart","year":"2002","journal-title":"American Journal of Medicine"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"EJ Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hrthm.2015.07.031","article-title":"Atrial flutter: clinical risk factors and adverse outcomes in the Framingham Heart Study","volume":"13","author":"F Rahman","year":"2016","journal-title":"Heart Rhythm"},{"key":"ref6","article-title":"Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study","author":"JS Healey","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"PA Wolf","year":"1991","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"A Odutayo","year":"2016","journal-title":"BMJ"},{"issue":"18","key":"ref9","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"AS Go","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/hrt.2002.008748","article-title":"Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK","volume":"90","author":"S Stewart","year":"2004","journal-title":"Heart"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics-2016 Update: a report from the American Heart Association","volume":"133","author":"D Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"21","key":"ref12","first-page":"e1","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"CT January","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"13","key":"ref13","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"RL Page","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FJC.0b013e31816d5f49","article-title":"Therapeutic considerations in applying rate control therapy for atrial fibrillation","volume":"52","author":"DG Wyse","year":"2008","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"15","key":"ref15","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","article-title":"Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management","volume":"66","author":"R Gopinathannair","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"JS Shinbane","year":"1997","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2015.01.013","article-title":"Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation","volume":"115","author":"AJ Ouyang","year":"2015","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/FJC.0000000000000274","article-title":"Digoxin is associated with increased all-cause mortality in patients with atrial fibrillation regardless of concomitant heart failure: a meta-analysis","volume":"66","author":"ZQ Wang","year":"2015","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5603\/CJ.a2016.0016","article-title":"Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation","volume":"23","author":"W Qureshi","year":"2016","journal-title":"Cardiology Journal"},{"issue":"28","key":"ref20","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","article-title":"Digoxin-associated mortality: a systematic review and meta-analysis of the literature","volume":"36","author":"M Vamos","year":"2015","journal-title":"European Heart Journal"},{"issue":"27","key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7270","article-title":"Evaluating non-randomised intervention studies","volume":"7","author":"JJ Deeks","year":"2003","journal-title":"Health Technology Assessment"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejim.2016.03.020","article-title":"Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them","volume":"32","author":"S Garattini","year":"2016","journal-title":"European Journal of Internal Medicine"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"ref24","article-title":"Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis","author":"N Sethi","year":"2016","journal-title":"PROSPERO"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13643-017-0470-2","article-title":"Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis","volume":"6","author":"NJ Sethi","year":"2017","journal-title":"Systematic Reviews"},{"key":"ref26","unstructured":"Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 The Cochrane Collaboration. 2011;<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.handbook.cochrane.org\" xlink:type=\"simple\">www.handbook.cochrane.org<\/ext-link>."},{"key":"ref27","first-page":"Mr000033","article-title":"Industry sponsorship and research outcome","volume":"2","author":"A Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"LL Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"LL Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"9128","key":"ref30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"D Moher","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"KF Schulz","year":"1995","journal-title":"JAMA"},{"issue":"7644","key":"ref32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"L Wood","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"J Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"ref34","first-page":"231","article-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) adopts consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use","volume":"48","year":"1997","journal-title":"International Digest of Health Legislation"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2288-10-90","article-title":"Evidence at a glance: error matrix approach for overviewing available evidence","volume":"10","author":"F Keus","year":"2010","journal-title":"BMC Medical Research Methodology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"JC Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"ref37","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. 2014."},{"key":"ref38","article-title":"Stata: Release 14. Statistical Software","year":"2014"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"J Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"ref40","unstructured":"Copenhagen Trial Unit. TSA\u2014Trial Sequential Analysis. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ctu.dk\/tsa\/\" xlink:type=\"simple\">http:\/\/www.ctu.dk\/tsa\/<\/ext-link>."},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"J Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive\u2014Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"J Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"K Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"J Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"ref45","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"K Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"ref46","unstructured":"Thorlund K EJ, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). 2011. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ctu.dk\/tsa\/files\/tsa_manual.pdf\" xlink:type=\"simple\">http:\/\/www.ctu.dk\/tsa\/files\/tsa_manual.pdf<\/ext-link>."},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1213\/ANE.0000000000000892","article-title":"Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection","volume":"121","author":"G Imberger","year":"2015","journal-title":"Anesthesia and Analgesia"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"e011890","DOI":"10.1136\/bmjopen-2016-011890","article-title":"False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review","volume":"6","author":"G Imberger","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"GR Norman","year":"2003","journal-title":"Medical Care"},{"key":"ref50","first-page":"Ed000111","article-title":"Viewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviews","volume":"3","author":"JC Jakobsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7650","key":"ref51","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"ref52","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"HJ Schunemann","year":"2003","journal-title":"CMAJ"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/hrt.64.4.256","article-title":"Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation","volume":"64","author":"EL Ang","year":"1990","journal-title":"British Heart Journal"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00044011-199509050-00005","article-title":"A randomized study comparing digoxin and propafenone in the treatment of recent onset atrial fibrillation","volume":"9","author":"R Baroffio","journal-title":"Clinical Drug Investigation"},{"issue":"5","key":"ref56","first-page":"584","article-title":"Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation","volume":"82","author":"L Bianconi","year":"1998","journal-title":"PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial. American Journal of Cardiology"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/j.1540-8159.1994.tb03810.x","article-title":"Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm","volume":"17","author":"GL Botto","year":"1994","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"66A","DOI":"10.1016\/0735-1097(95)91727-F","article-title":"Effect of single loading oral propafenone or digoxin in recent onset atrial fibrillation: conversion to sinus rhythm and modulation of ventricular rate. A randomized, placebo controlled study","volume":"25","author":"GL Botto","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/1010-7940(94)90114-7","article-title":"A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery","volume":"8","author":"AD Cochrane","year":"1994","journal-title":"European Journal of Cardiothoracic Surgery"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005344-198603000-00005","article-title":"A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction","volume":"8","author":"JC Cowan","year":"1986","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"ref61","first-page":"478A","article-title":"The results of CRAFT-1: A multi-center, double-blind, placebo-controlled crossover study of digoxin in symptomatic paroxysmal atrial fibrillation","volume":"21","author":"FD Murgatroyd","year":"1993","journal-title":"Journal of the American College of Cardiology"},{"issue":"21","key":"ref62","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/01.CIR.99.21.2765","article-title":"Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation","volume":"99","author":"FD Murgatroyd","year":"1999","journal-title":"Circulation"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1540-8159.1996.tb03263.x","article-title":"Effect of digoxin on the ventricular rate variability during paroxysmal atrial fibrillation","volume":"19","author":"K Hnatkova","year":"1996","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"9","key":"ref64","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/j.1540-8159.1998.tb00272.x","article-title":"Mid- and long-term similarity of ventricular response to paroxysmal atrial fibrillation: digoxin Versus placebo","volume":"21","author":"K Hnatkova","year":"1998","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"ref65","first-page":"I","article-title":"The DIGAF study (digoxin in atrial fibrillation): cardioversion of atrial fibrillation with high dose digoxin","volume":"96","author":"HG Stuhlinger","year":"1997","journal-title":"Circulation"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/clc.4960220208","article-title":"Effects of digoxin on electrocardiogram in patients with acute atrial fibrillation\u2014a randomized, placebo-controlled study. Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group","volume":"22","author":"B Hornestam","year":"1999","journal-title":"Clinical Cardiology"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/oxfordjournals.eurheartj.a015311","article-title":"Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group","volume":"18","author":"K Karki","year":"1997","journal-title":"European Heart Journal"},{"issue":"4","key":"ref68","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-106-4-503","article-title":"Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial","volume":"106","author":"RH Falk","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"ref69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/14017439209099077","article-title":"Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment","volume":"26","author":"E Hjelms","year":"1992","journal-title":"Scandinavian Journal of Thoracic and Cardiovascular Surgery"},{"issue":"1","key":"ref70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2005.06.048","article-title":"Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate","volume":"110","author":"R Hofmann","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/2000-1967-175","article-title":"The effect of digitalis or a beta-blocker, alone or in combination, on atrial fibrillation at rest and during exercise","volume":"106","author":"K Holming","year":"2001","journal-title":"Upsala Journal of Medical Sciences"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.eurheartj.a060945","article-title":"Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study","volume":"16","author":"ZY Hou","year":"1995","journal-title":"European Heart Journal"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0196-0644(97)70318-4","article-title":"Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation","volume":"29","author":"GD Innes","year":"1997","journal-title":"Annals of Emergency Medicine"},{"issue":"4","key":"ref74","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1253\/circj.CJ-12-1618","article-title":"Urgent management of rapid heart rate in patients with atrial fibrillation\/flutter and left ventricular dysfunction: comparison of the ultra-short-acting beta 1-selective blocker landiolol with digoxin (J-Land Study)","volume":"77","author":"R Nagai","year":"2013","journal-title":"Circulation Journal"},{"issue":"4","key":"ref75","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.eurheartj.a015310","article-title":"Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo","volume":"18","author":"L Jordaens","year":"1997","journal-title":"European Heart Journal"},{"issue":"1","key":"ref76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mem.2000.107655","article-title":"A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation","volume":"36","author":"AP Joseph","year":"2000","journal-title":"Annals of Emergency Medicine"},{"issue":"1","key":"ref77","first-page":"e29","article-title":"Intravenous amiodarone versus digoxin in atrial fibrillation rate control; a clinical trial","volume":"5","author":"M Shojaee","year":"2017","journal-title":"Emergency (Tehran, Iran)"},{"issue":"2","key":"ref78","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1067\/mhj.2001.116761","article-title":"Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial","volume":"142","author":"CS Simpson","year":"2001","journal-title":"American Heart Journal"},{"issue":"7","key":"ref79","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1097\/CCM.0b013e3181a02f56","article-title":"Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation","volume":"37","author":"CW Siu","year":"2009","journal-title":"Critical Care Medicine"},{"issue":"1","key":"ref80","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1016\/S0002-8703(03)00526-X","article-title":"Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial","volume":"147","author":"SP Thomas","year":"2004","journal-title":"American Heart Journal"},{"issue":"5","key":"ref81","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-8703(98)70031-6","article-title":"A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery","volume":"135","author":"JE Tisdale","year":"1998","journal-title":"American Heart Journal"},{"issue":"5\u20136","key":"ref82","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1440-1681.2001.03454.x","article-title":"Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation","volume":"28","author":"HF Tse","year":"2001","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"7","key":"ref83","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1540-8167.2001.00766.x","article-title":"VERDICT: the Verapamil versus Digoxin Cardioversion Trial: a randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation","volume":"12","author":"T Van Noord","year":"2001","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"2","key":"ref84","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1378\/chest.119.2.502","article-title":"Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin Vs IV diltiazem alone","volume":"119","author":"N Wattanasuwan","year":"2001","journal-title":"Chest"},{"issue":"1","key":"ref85","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0196-0644(97)70319-6","article-title":"Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin","volume":"29","author":"DM Schreck","year":"1997","journal-title":"Annals of Emergency Medicine"},{"issue":"5","key":"ref86","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.0954-6820.1983.tb08608.x","article-title":"Digoxin and the geriatric in-patient. A randomized trial of digoxin versus placebo","volume":"214","author":"K Boman","year":"1983","journal-title":"Acta Medica Scandinavica"},{"issue":"2","key":"ref87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.eurheartj.a062241","article-title":"Towards improved control of atrial fibrillation","volume":"8","author":"KS Channer","year":"1987","journal-title":"European Heart Journal"},{"issue":"1","key":"ref88","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2125.1979.tb05909.x","article-title":"Comparison of medigoxin and digoxin in the control of atrial fibrillation","volume":"8","author":"P Coburn","year":"1979","journal-title":"British journal of Clinical Pharmacology"},{"issue":"2","key":"ref89","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0735-1097(98)00561-0","article-title":"Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens","volume":"33","author":"R Farshi","year":"1999","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"ref90","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjcard.2008.09.064","article-title":"Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure","volume":"103","author":"L Fauchier","year":"2009","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"ref91","first-page":"395","article-title":"A comparison of digoxin and medigoxin in treating atrial fibrillation","volume":"73","author":"E Halley","year":"1980","journal-title":"Irish Medical Journal"},{"issue":"11","key":"ref92","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"AU Khand","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"ref93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9149(99)80538-4","article-title":"Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation","volume":"75","author":"KK Koh","year":"1995","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"ref94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1378\/chest.83.3.491","article-title":"Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation","volume":"83","author":"R Lang","year":"1983","journal-title":"Chest"},{"issue":"2","key":"ref95","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/oxfordjournals.eurheartj.a062242","article-title":"A comparison of verapamil and digoxin in the treatment of atrial fibrillation","volume":"8","author":"R Lewis","year":"1987","journal-title":"European Heart Journal"},{"issue":"7","key":"ref96","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/eurheartj\/9.7.777","article-title":"Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem","volume":"9","author":"RV Lewis","year":"1988","journal-title":"European Heart Journal"},{"issue":"3","key":"ref97","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/oxfordjournals.eurheartj.a062497","article-title":"A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation","volume":"9","author":"RV Lewis","year":"1988","journal-title":"European Heart Journal"},{"issue":"5","key":"ref98","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/hrt.2003.017707","article-title":"Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil","volume":"90","author":"CJA Lindholm","year":"2004","journal-title":"Heart"},{"issue":"2","key":"ref99","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-8703(88)90610-2","article-title":"Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels","volume":"116","author":"I Maragno","year":"1988","journal-title":"American Heart Journal"},{"issue":"2","key":"ref100","first-page":"201","article-title":"A comparison of verapamil and digoxin for heart rate control in atrial fibrillation","volume":"2","author":"MA Moghadam","year":"2102","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"4","key":"ref101","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/cs0740351","article-title":"Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation","volume":"74","author":"SM Pomfret","year":"1988","journal-title":"Clinical Science (London, England: 1979)"},{"issue":"2","key":"ref102","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.73.2.316","article-title":"Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart-rate at rest and during exercise in patients with chronic atrial fibrillation","volume":"73","author":"A Roth","year":"1986","journal-title":"Circulation"},{"issue":"5","key":"ref103","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2006.05.043","article-title":"Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation","volume":"48","author":"MEW Hemels","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"17","key":"ref104","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/0002-9149(90)91102-C","article-title":"Usefulness of labetalol in chronic atrial fibrillation","volume":"66","author":"CK Wong","year":"1990","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"ref105","first-page":"1252","article-title":"Comparison between digoxin and atenolol in chronic atrial fibrillation","volume":"123","author":"F Lanas","year":"1995","journal-title":"Revista Medica de Chile"},{"issue":"7","key":"ref106","doi-asserted-by":"crossref","first-page":"e015099","DOI":"10.1136\/bmjopen-2016-015099","article-title":"A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial","volume":"7","author":"D Kotecha","year":"2017","journal-title":"BMJ Open"},{"key":"ref107","unstructured":"European Medicines Agency. Guideline on multiplicity issues in clinical trials. 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en\u2026guideline\/\u2026\/WC500224998.pdf\" xlink:type=\"simple\">www.ema.europa.eu\/docs\/en\u2026guideline\/\u2026\/WC500224998.pdf<\/ext-link>."},{"issue":"2","key":"ref108","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/heartjnl-2012-302301","article-title":"Heart rate: surrogate or target in the management of heart failure?","volume":"99","author":"M Bohm","year":"2013","journal-title":"Heart"},{"issue":"2","key":"ref109","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.hrthm.2004.03.070","article-title":"Overview of endpoints in atrial fibrillation studies","volume":"1","author":"DG Wyse","year":"2004","journal-title":"Heart Rhythm"},{"issue":"15","key":"ref110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"IC Van Gelder","year":"2010","journal-title":"NEJM"},{"issue":"11","key":"ref111","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7326\/M13-1467","article-title":"Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review","volume":"160","author":"SM Al-Khatib","year":"2014","journal-title":"Annals of Internal Medicine"},{"key":"ref112","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","author":"P Kirchhof","year":"2016","journal-title":"European Heart Journal"},{"key":"ref113","unstructured":"Macle L, Andrade J, Atzema C, Bell AD, Cairns JA, Connolly S, et al. Supplementary material: complete guidelines listing\u20142010 to 2016. Available from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ccs.ca\/images\/Guidelines\/Guidelines_POS_Library\/2016%20AF%20Update_Supplement_Final_PDF.pdf\" xlink:type=\"simple\">https:\/\/www.ccs.ca\/images\/Guidelines\/Guidelines_POS_Library\/2016%20AF%20Update_Supplement_Final_PDF.pdf<\/ext-link>"},{"issue":"3","key":"ref114","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"AW Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"ref115","doi-asserted-by":"crossref","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"7","author":"KF Schulz","year":"2010","journal-title":"PLoS Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T03:46:20Z","timestamp":1589859980000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193924"}},"subtitle":[],"editor":[{"given":"Nanette H.","family":"Bishopric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":115,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193924","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,8]]}}}